INSIGHTS

Articles & Insights.

Thought leadership on the legal, regulatory, and business issues shaping the healthcare industry.

REAL ISSUES.

PRACTICAL INSIGHTS.

AHEAD OF THE CURVE.

Healthcare Investors: Why Regulatory Due Diligence Must Go Beyond the Financial Statements

A healthcare company can have impressive revenue, strong margins, and rapid growth while still carrying significant regulatory risk.

That is why healthcare investors should look beyond conventional financial and corporate due diligence when evaluating an acquisition or investment.

The question is not simply whether the company makes money. Investors should understand how the company makes money.

Follow the Revenue

Consider a medical business generating substantial revenue through a network of providers.

Financial diligence may confirm revenue, expenses, EBITDA, and historical growth. Healthcare regulatory diligence asks additional questions.

Who actually provides the medical services?

Which entity bills for those services?

Under whose NPI are claims submitted?

Who owns the professional practice?

Who controls its bank account?

How is the management company compensated?

Where do patient referrals originate?

Are any referral sources receiving compensation?

Those questions can reveal risks that may not appear on a conventional balance sheet.

Examine the MSO-PC Relationship

Investors increasingly encounter healthcare businesses structured through a Management Services Organization (“MSO”) and one or more affiliated professional practices.

That structure may be entirely appropriate. But investors should understand the substance of the relationship.

A diligence review should examine the Management Services Agreement as well as governance documents, banking arrangements, physician-owner relationships, succession mechanisms, provider agreements, management fees, and the actual allocation of authority.

If the physician technically owns the professional practice but the MSO effectively controls every material decision, corporate-practice concerns may exist depending on applicable state law.

Review Marketing and Referral Relationships

Marketing deserves particular attention.

Healthcare businesses frequently use lead generators, affiliates, call centers, independent sales representatives, or other marketing partners.

An agreement to pay someone based on each patient, prescription, order, or healthcare service generated can create issues under federal or state fraud-and-abuse laws depending on the circumstances.

Investors should therefore understand not only how much the company spends on marketing, but how marketers are compensated and what they are being compensated for.

Look at Ancillary Revenue

Laboratories, pharmacies, diagnostic services, remote patient monitoring, durable medical equipment, and other ancillary businesses can create additional revenue streams.

They can also create regulatory exposure where financial relationships overlap with patient referrals.

Diligence should identify ownership interests, referral relationships, compensation arrangements, billing practices, and disclosures associated with ancillary services.

Consider the Expansion Plan

Investors are generally investing in where a business is going—not merely where it is today.

A model operating legally in one state may require substantial modification when expanded into another. Professional ownership rules, facility licensing, provider scope of practice, telehealth requirements, and prescribing laws can differ significantly by jurisdiction.

Those issues should be identified before an aggressive expansion plan is incorporated into the investment thesis.

Regulatory Infrastructure Is Part of Enterprise Value

Good healthcare regulatory infrastructure does more than reduce legal risk.

Clean entity structures, defensible contracts, documented provider relationships, appropriate licensing, organized compliance records, and scalable MSO structures can make a company easier to finance, acquire, and expand.

Apex Health Law works with healthcare investors, operators, and founders to evaluate the regulatory architecture underlying healthcare businesses and structure transactions with both compliance and future growth in mind.

This article is provided for general informational purposes only and does not constitute legal advice.

Share:

More Posts

Send A Message